Perrigo Co. plc Stock
Perrigo Co. plc Stock
Perrigo Co. plc gained 0.520% compared to yesterday.
Our community is currently high on Perrigo Co. plc with 3 Buy predictions and 0 Sell predictions.
As a result the target price of 35 € shows a slightly positive potential of 13.75% compared to the current price of 30.77 € for Perrigo Co. plc.
For the coming years our community has positive and negative things to say abot the Perrigo Co. plc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Perrigo Co. plc in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Perrigo Co. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Perrigo Co. plc | 0.520% | 4.901% | 2.615% | -7.857% | 5.443% | -12.040% | -28.146% |
| Cosmo Pharmaceuticals S.A. | -0.670% | -3.871% | 3.472% | - | - | - | - |
| Sihuan Pharmaceutical Holdings Group Ltd. | -1.600% | 7.895% | 5.128% | -29.714% | -10.219% | -80.901% | -72.422% |
| Almirall S.A. | -0.350% | 1.192% | 2.598% | -8.857% | 0.236% | -35.191% | - |
Comments
Perrigo Company plc (NYSE: PRGO) had its price target raised by analysts at Piper Sandler from $35.00 to $39.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PRGO provided by MarketBeat
Perrigo Company plc (NYSE: PRGO) had its price target lowered by analysts at JPMorgan Chase & Co. from $48.00 to $41.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PRGO provided by MarketBeat
Perrigo Company plc (NYSE: PRGO) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $37.00 price target on the stock.
Show more
Ratings data for PRGO provided by MarketBeat